These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10468300)
1. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Hickey KP; Boyle KP; Jepps HM; Andrew AC; Buxton EJ; Burns PA Br J Cancer; 1999 Aug; 80(11):1803-8. PubMed ID: 10468300 [TBL] [Abstract][Full Text] [Related]
2. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients]. Zhang H; Li Z; Chen M; Zhang G; Xu K Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406 [TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of peritoneal fluid in ovarian cancer patients. Parrella P; Zangen R; Sidransky D; Nicol T Mod Pathol; 2003 Jul; 16(7):636-40. PubMed ID: 12861058 [TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Schwarzenbach H; Müller V; Stahmann N; Pantel K Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935 [TBL] [Abstract][Full Text] [Related]
5. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957 [TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum. Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study. Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342 [TBL] [Abstract][Full Text] [Related]
8. Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Chen X; Bonnefoi H; Diebold-Berger S; Lyautey J; Lederrey C; Faltin-Traub E; Stroun M; Anker P Clin Cancer Res; 1999 Sep; 5(9):2297-303. PubMed ID: 10499596 [TBL] [Abstract][Full Text] [Related]
9. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330 [TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma of the esophagus can be detected by microsatellite analysis in tumor and serum. Eisenberger CF; Knoefel WT; Peiper M; Merkert P; Yekebas EF; Scheunemann P; Steffani K; Stoecklein NH; Hosch SB; Izbicki JR Clin Cancer Res; 2003 Sep; 9(11):4178-83. PubMed ID: 14519643 [TBL] [Abstract][Full Text] [Related]
11. The detection of oesophageal adenocarcinoma by serum microsatellite analysis. Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865 [TBL] [Abstract][Full Text] [Related]
12. Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Taback B; Giuliano AE; Hansen NM; Singer FR; Shu S; Hoon DS Cancer Res; 2003 Apr; 63(8):1884-7. PubMed ID: 12702578 [TBL] [Abstract][Full Text] [Related]
13. Allele loss on chromosome 1p36 in epithelial ovarian cancers. Alvarez AA; Lambers AR; Lancaster JM; Maxwell GL; Ali S; Gumbs C; Berchuck A; Futreal PA Gynecol Oncol; 2001 Jul; 82(1):94-8. PubMed ID: 11426968 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite alterations plasma DNA of primary breast cancer patients. Shaw JA; Smith BM; Walsh T; Johnson S; Primrose L; Slade MJ; Walker RA; Coombes RC Clin Cancer Res; 2000 Mar; 6(3):1119-24. PubMed ID: 10741742 [TBL] [Abstract][Full Text] [Related]
15. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer. Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite alterations in serum DNA of patients with colorectal cancer. Kölble K; Ullrich OM; Pidde H; Barthel B; Diermann J; Rudolph B; Dietel M; Schlag PM; Scherneck S Lab Invest; 1999 Sep; 79(9):1145-50. PubMed ID: 10496533 [TBL] [Abstract][Full Text] [Related]
17. High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Ellsworth RE; Ellsworth DL; Lubert SM; Hooke J; Somiari RI; Shriver CD Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):915-9. PubMed ID: 14504204 [TBL] [Abstract][Full Text] [Related]
18. [Quantitative analysis of circulating DNA in serum of cancer patients]. Tu H; Gao HF; Fu SL; Chen H Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):606-8. PubMed ID: 15634521 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma. Kakimoto Y; Yamamoto N; Shibahara T Oncol Rep; 2008 Nov; 20(5):1195-200. PubMed ID: 18949421 [TBL] [Abstract][Full Text] [Related]
20. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]